24
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      European Achondroplasia Forum Practical Considerations for Following Adults with Achondroplasia

      brief-report

      Read this article at

      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Achondroplasia is a lifelong condition requiring lifelong management. There is consensus that infants and children with achondroplasia should be managed by a multidisciplinary team experienced in the condition. However, many people are lost to follow-up after the transition from paediatric to adult care, and there is no standardised approach for management in adults, despite the recent availability of international consensus guidelines. To address this, the European Achondroplasia Forum has developed a patient-held checklist to support adults with achondroplasia in managing their health. The checklist highlights key symptoms of spinal stenosis and obstructive sleep apnoea, both among the most frequent and potentially severe medical complications in adults with achondroplasia. The checklist acts as a framework to support individuals and their primary care provider in completing a routine review. General advice on issues such as blood pressure, pain, hearing, weight, adaptive aids, and psychosocial aspects are also included. The checklist provides key symptoms to be aware of, in addition to action points so that people can approach their primary care provider and be directed to the appropriate specialist, if needed. Additionally, the European Achondroplasia Forum offers some ideas on implementing the checklist during the transition from paediatric to adult care, thus ensuring the existing multidisciplinary team model in place during childhood can support in engaging individuals and empowering them to take responsibility for their own care as they move into adulthood.

          Related collections

          Most cited references57

          • Record: found
          • Abstract: found
          • Article: found
          Is Open Access

          Hearing loss prevalence and years lived with disability, 1990–2019: findings from the Global Burden of Disease Study 2019

          Summary Background Hearing loss affects access to spoken language, which can affect cognition and development, and can negatively affect social wellbeing. We present updated estimates from the Global Burden of Disease (GBD) study on the prevalence of hearing loss in 2019, as well as the condition's associated disability. Methods We did systematic reviews of population-representative surveys on hearing loss prevalence from 1990 to 2019. We fitted nested meta-regression models for severity-specific prevalence, accounting for hearing aid coverage, cause, and the presence of tinnitus. We also forecasted the prevalence of hearing loss until 2050. Findings An estimated 1·57 billion (95% uncertainty interval 1·51–1·64) people globally had hearing loss in 2019, accounting for one in five people (20·3% [19·5–21·1]). Of these, 403·3 million (357·3–449·5) people had hearing loss that was moderate or higher in severity after adjusting for hearing aid use, and 430·4 million (381·7–479·6) without adjustment. The largest number of people with moderate-to-complete hearing loss resided in the Western Pacific region (127·1 million people [112·3–142·6]). Of all people with a hearing impairment, 62·1% (60·2–63·9) were older than 50 years. The Healthcare Access and Quality (HAQ) Index explained 65·8% of the variation in national age-standardised rates of years lived with disability, because countries with a low HAQ Index had higher rates of years lived with disability. By 2050, a projected 2·45 billion (2·35–2·56) people will have hearing loss, a 56·1% (47·3–65·2) increase from 2019, despite stable age-standardised prevalence. Interpretation As populations age, the number of people with hearing loss will increase. Interventions such as childhood screening, hearing aids, effective management of otitis media and meningitis, and cochlear implants have the potential to ameliorate this burden. Because the burden of moderate-to-complete hearing loss is concentrated in countries with low health-care quality and access, stronger health-care provision mechanisms are needed to reduce the burden of unaddressed hearing loss in these settings. Funding Bill & Melinda Gates Foundation and WHO.
            Bookmark
            • Record: found
            • Abstract: not found
            • Article: not found

            Assessing adiposity: a scientific statement from the American Heart Association.

              Bookmark
              • Record: found
              • Abstract: found
              • Article: found
              Is Open Access

              Achondroplasia: a comprehensive clinical review

              Achondroplasia is the most common of the skeletal dysplasias that result in marked short stature (dwarfism). Although its clinical and radiologic phenotype has been described for more than 50 years, there is still a great deal to be learned about the medical issues that arise secondary to this diagnosis, the manner in which these are best diagnosed and addressed, and whether preventive strategies can ameliorate the problems that can compromise the health and well being of affected individuals. This review provides both an updated discussion of the care needs of those with achondroplasia and an exploration of the limits of evidence that is available regarding care recommendations, controversies that are currently present, and the many areas of ignorance that remain.
                Bookmark

                Author and article information

                Contributors
                svfred@sunnaas.no
                Journal
                Adv Ther
                Adv Ther
                Advances in Therapy
                Springer Healthcare (Cheshire )
                0741-238X
                1865-8652
                15 May 2024
                15 May 2024
                2024
                : 41
                : 7
                : 2545-2558
                Affiliations
                [1 ]GRID grid.416731.6, ISNI 0000 0004 0612 1014, Sunnaas Rehabilitation Hospital, , TRS National Resource Centre for Rare Disorders, ; Nesodden, Norway
                [2 ]Department of Medical Genomics, King Faisal Specialist Hospital and Research Centre, ( https://ror.org/05n0wgt02) Riyadh, Kingdom of Saudi Arabia
                [3 ]Faculty of Medicine, Alfaisal University, ( https://ror.org/00cdrtq48) Riyadh, Kingdom of Saudi Arabia
                [4 ]GRID grid.413548.f, ISNI 0000 0004 0571 546X, Division of Genetics and Genomic Medicine, , Sidra Medicine and Hamad Medical Corporation, ; Doha, Qatar
                [5 ]Istituto Giannina Gaslini, ( https://ror.org/0424g0k78) Genoa, Italy
                [6 ]GRID grid.508487.6, ISNI 0000 0004 7885 7602, Paris Descartes University, ; Paris, France
                [7 ]GRID grid.412134.1, ISNI 0000 0004 0593 9113, Necker University Hospital and Paris Cité University, ; Paris, France
                [8 ]Medical Genetics Division and Pediatrics Department, Virgen de la Arrixaca University Hospital, IMIB-Pascual Parrilla, University of Murcia, ( https://ror.org/03p3aeb86) Murcia, Spain
                [9 ]CIBERER-ISCIII, Madrid, Spain
                [10 ]BKMF e.V., Leinestraße 2, 28199 Bremen, Germany
                [11 ]University Medical Centre Mannheim, ( https://ror.org/05sxbyd35) Mannheim, Germany
                [12 ]GRID grid.411778.c, ISNI 0000 0001 2162 1728, Clinic of Child and Youth Medicine, , University Hospital Mannheim, ; Mannheim, Germany
                [13 ]GRID grid.419504.d, ISNI 0000 0004 1760 0109, Paediatric Endocrinology Unit, , IRCCS Istituto Giannina Gaslini, ; 16147 Genoa, Italy
                [14 ]Department of Neuroscience, Rehabilitation, Ophthalmology, Genetics, Maternal and Child Health, University of Genoa, ( https://ror.org/0107c5v14) 16147 Genoa, Italy
                [15 ]Children’s Hospital, Otto-von-Guericke-University, ( https://ror.org/00ggpsq73) Magdeburg, Germany
                [16 ]GRID grid.410569.f, ISNI 0000 0004 0626 3338, Centre for Human Genetics, , University Hospitals Leuven, ; Leuven, Belgium
                [17 ]GRID grid.412134.1, ISNI 0000 0004 0593 9113, Hôpital Necker, ; Paris, France
                [18 ]Italian Association on Achondroplasia, Milan, Italy
                [19 ]GRID grid.28911.33, ISNI 0000000106861985, Medical Genetics Department, Hospital Pediátrico de Coimbra, , Unidade Local de Saúde de Coimbra, ; Coimbra, Portugal
                [20 ]GRID grid.28911.33, ISNI 0000000106861985, Clinical Academic Center of Coimbra, Hospital Pediátrico de Coimbra, , Unidade Local de Saúde de Coimbra, ; Coimbra, Portugal
                [21 ]University Clinic of Genetics, Faculty of Medicine, University of Coimbra, ( https://ror.org/04z8k9a98) Coimbra, Portugal
                [22 ]ERN-BOND, ( https://ror.org/04crk2m06) Bologna, Italy
                [23 ]Guy’s and St Thomas’ NHS Foundation Trust, ( https://ror.org/00j161312) London, UK
                Author information
                http://orcid.org/0000-0002-2804-5783
                http://orcid.org/0000-0002-7183-5238
                http://orcid.org/0000-0001-9871-4578
                http://orcid.org/0000-0003-3921-1334
                Article
                2880
                10.1007/s12325-024-02880-3
                11213767
                38748332
                e76556c2-c5a9-4079-80db-22ec8b42071c
                © The Author(s) 2024

                Open Access This article is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License, which permits any non-commercial use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by-nc/4.0/.

                History
                : 22 March 2024
                : 19 April 2024
                Funding
                Funded by: FundRef http://dx.doi.org/10.13039/100008484, BioMarin Pharmaceutical;
                Funded by: FundRef http://dx.doi.org/10.13039/100004339, Sanofi;
                Funded by: Ascendis
                Funded by: QED Therapeutics
                Categories
                Commentary
                Custom metadata
                © Springer Healthcare Ltd., part of Springer Nature 2024

                achondroplasia,adult,assessment,checklist,eaf,follow-up,sleep apnoea,spinal stenosis,transition

                Comments

                Comment on this article

                scite_
                0
                0
                0
                0
                Smart Citations
                0
                0
                0
                0
                Citing PublicationsSupportingMentioningContrasting
                View Citations

                See how this article has been cited at scite.ai

                scite shows how a scientific paper has been cited by providing the context of the citation, a classification describing whether it supports, mentions, or contrasts the cited claim, and a label indicating in which section the citation was made.

                Similar content269

                Most referenced authors1,451